Use of antivirals or monoclonal antibodies is not recommended for children less than 18 years of age, irrespective of the severity of infection, the Health Ministry said on Thursday, while releasing the revised ‘Comprehensive Guidelines for Management of COVID-19’ in children and adolescents.
“Children who develop any organ specific dysfunction during hospital stay or subsequently should receive appropriate care,” state the guidelines.
